Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
Example: dental hygienist
Public Assessment Report Decentralised Procedure …
Public Assessment Report Decentralised Procedure CANDESARTAN CILEXETIL 8MG, 16MG AND 32MG. TABLETS. CANDESARTAN CILEXETIL. UK/H/ 3930 , 4698 & 4699/001-3/DC. UK Licence No: PL 00289/1176-8, 1535-7 & 1540-2. TEVA UK LIMITED. PAR Candesartan Cilexetil 8 mg, 16 mg and 32 mg Tablets UK/H/ 3930 , 4698 & 4699/001-3/DC. LAY SUMMARY. On 3rd November 2011, the MHRA granted Teva UK Limited Marketing Authorisations (licences) for Candesartan cilexetil 8 mg, 16 mg and 32 mg Tablets. Candesartan cilexetil 8 mg, 16 mg and 32 mg Tablets contain the active ingredient, candesartan cilexetil. Candesartan cilexetil belongs to a group of medicines called Angiotensin II receptor antagonists.
PAR Candesartan Cilexetil 8 mg, 16 mg and 32 mg Tablets UK/H/3930, 4698 & 4699/001-3/DC 2 LAY SUMMARY On 3rd November 2011, the MHRA granted Teva UK Limited Marketing Authorisations (licences) for Candesartan cilexetil 8 …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: